These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17004270)

  • 101. Effective Estimation of Ligand-Binding Affinity Using Biased Sampling Method.
    Ngo ST; Vu KB; Bui LM; Vu VV
    ACS Omega; 2019 Feb; 4(2):3887-3893. PubMed ID: 31459599
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals.
    Parthasarathy A; Cross PJ; Dobson RCJ; Adams LE; Savka MA; Hudson AO
    Front Mol Biosci; 2018; 5():29. PubMed ID: 29682508
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Structure of type II dehydroquinase from Pseudomonas aeruginosa.
    Reiling S; Kelleher A; Matsumoto MM; Robinson G; Asojo OA
    Acta Crystallogr F Struct Biol Commun; 2014 Nov; 70(Pt 11):1485-91. PubMed ID: 25372814
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Resistance in tuberculosis: what do we know and where can we go?
    Green KD; Garneau-Tsodikova S
    Front Microbiol; 2013; 4():208. PubMed ID: 23888158
    [TBL] [Abstract][Full Text] [Related]  

  • 105. New molecular scaffolds for the design of Mycobacterium tuberculosis type II dehydroquinase inhibitors identified using ligand and receptor based virtual screening.
    Kumar A; Siddiqi MI; Miertus S
    J Mol Model; 2010 Apr; 16(4):693-712. PubMed ID: 19816720
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
    Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
    ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Rational design, synthesis, and evaluation of nanomolar type II dehydroquinase inhibitors.
    Payne RJ; Peyrot F; Kerbarh O; Abell AD; Abell C
    ChemMedChem; 2007 Jul; 2(7):1015-29. PubMed ID: 17487900
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
    Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
    J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.
    Prazeres VF; Tizón L; Otero JM; Guardado-Calvo P; Llamas-Saiz AL; van Raaij MJ; Castedo L; Lamb H; Hawkins AR; González-Bello C
    J Med Chem; 2010 Jan; 53(1):191-200. PubMed ID: 19911771
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Progress in type II dehydroquinase inhibitors: from concept to practice.
    González-Bello C; Castedo L
    Med Res Rev; 2007 Mar; 27(2):177-208. PubMed ID: 17004270
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Inhibitors of types I and II dehydroquinase.
    Le Sann C; Gower MA; Abell AD
    Mini Rev Med Chem; 2004 Sep; 4(7):747-56. PubMed ID: 15379642
    [TBL] [Abstract][Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.